Awakn Life Sciences has strengthened its intellectual property portfolio and pipeline for the treatment of addictions with the filing of a patent application for a new chemical series of entactogen-like molecules.
The team at Awakn hope to “treat addiction patients, more rapidly, effectively, and safely than has been possible” with these novel molecules.
Category Press Release
Published in Awakn Life Sciences